Effects of Clonorchis sinensis combined with Hepatitis B virus infection on the prognosis of patients with Hepatocellular Carcinoma following Hepatectomy (original) (raw)
Fig 3
Comparison of OS and RFS among patients of groups 1 to 4.
(A) The OS rates (P1–2 = 0.052, P2–3 = 0.05, P1–3 = 0.863, P3–4 < 0.001, P1–4 = 0.012, P2–4 = 0.924); (B) the RFS rates (P1–2 = 0.098, P2–3 = 0.206, P1–3 = 0.308, P3–4 = 0.028, P1–4 = 0.02, P2–4 = 0.976). Group 1 (n = 119), CS-negative + HBV-negative; group 2 (n = 38), CS-positive + HBV-negative; group 3 (n = 623), CS-negative + HBV-positive; group 4 (n = 166), CS-positive + HBV-positive. CS, Clonorchis sinensis; HBV, Hepatitis B virus; OS, overall survival; RFS, recurrence-free survival.